Keywords: fda, approves, serostim, aids, wasting, ares-serono, recombinant

FDA Approves Serostim For AIDS Wasting

Article | 02 September 1996

Print This

Ares-Serono's recombinant human growth hormone product Serostim has been cleared for marketing in the USA for AIDS wasting or cachexia. ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in